HiSiaddi is an innovative foreign trade service provider driven by both technology transformation and foreign trade business. We have established a "1+2+3+4=1" service system and can supply BINAP sourced directly from multiple well-known original manufacturers. With over a decade of market experience and long-term manufacturer technology transformation partnerships, HiSiaddi boasts extensive expertise resolving product compliance issues. Below is a case study of HiSiaddi addressing BINAP compliance challenges.
Contact HiSiaddi customer service for more inquiries on BINAP product compliance.
The client is a high-end pharmaceutical intermediate enterprise based in Berlin, Germany, specializing in R&D and production of chiral intermediates for anti-tumor drugs and supplying multiple top European pharmaceutical companies. All production lines hold FDA, EMA, and GMP certifications, representing a mid-to-high-end client with stringent compliance requirements. The client purchases 50 kg of 99.8% pharmaceutical-grade R-BINAP annually and previously sourced Takasago (Japan) products. Facing cost pressure, it switched to Chinese suppliers in 2025, yet encountered severe barriers in EU REACH compliance, GMP documentation completeness, and supply chain traceability after signing a 20 kg initial order. Goods faced detention and return risks, prompting the client to entrust HiSiaddi with resolving all compliance obstacles urgently.
As an EU-based enterprise, the client is bound by REACH Regulation (EC 1907/2006): annual imports exceeding 1 ton mandate full REACH registration alongside compliant SDS (Safety Data Sheet) and SVHC (Substances of Very High Concern) test reports. However, most Chinese manufacturers lack REACH registration and only provide Chinese-language MSDS, lacking EU-recognized English SDS, full SVHC test reports, and REACH Only Representative (OR) qualifications. This prevents customs clearance upon goods arrival, exposing the client to return shipments and substantial fines.
The client’s production holds EMA GMP certification, requiring raw material suppliers to deliver a complete GMP documentation chain: factory GMP certificates, DMF (Drug Master File) for raw materials, full batch traceability records, impurity traceability reports, and third-party audit reports. The Chinese manufacturer contacted only provided a basic COA (Certificate of Analysis), lacking GMP compliance certificates, DMF files, and full impurity traceability data. This blocked the client’s internal quality audit and prevented raw material introduction to pharmaceutical production lines.
EU pharmaceutical regulations mandate full end-to-end traceability, requiring raw material origin certificates, production process flowcharts, key raw material procurement vouchers, batch production records, export customs declarations, and Certificate of Origin (CO). Chinese manufacturers lack traceability awareness and cannot supply complete production records, key raw material traceability vouchers, or compliant CO documents, preventing the client from completing EU supply chain filing and delaying drug market approval timelines.
Explicit client requirements: Resolve all compliance issues within 7 days to guarantee customs clearance; deliver documentation fully aligned with EMA and REACH standards; establish a long-term compliance mechanism to secure stable supply of the annual 50 kg order with zero compliance defects to avoid delays to drug market launch schedules.
HiSiaddi assembled a special team consisting of REACH regulatory specialists, GMP auditors, and supply chain traceability officers to develop a one-stop solution of "compliance document supplementation + documentation restructuring + traceability linkage + long-term risk guarantee" targeting the three core dilemmas, fully implemented within 7 days.
· Secure REACH Only Representative (OR): Partner with Germany-based REACH compliance institution Chemreach to authorize OR representation within 24 hours. The German institution acts as the EU-only representative for Chinese manufacturers, bearing REACH registration and compliance responsibilities and resolving the core barrier of non-EU enterprises’ inability to register directly.
· Compile compliant SDS + SVHC testing: Draft 16-section English SDS aligned with EU CLP standards, supplemented with BINAP physicochemical properties, hazard classification, safe operating specifications, and REACH compliance declarations. Entrust TÜV Rheinland to conduct full SVHC 197-item testing and issue REACH-compliant test reports verifying BINAP contains no substances of very high concern.
· Complete REACH pre-registration & tonnage declaration: Submit BINAP REACH pre-registration to ECHA via the OR, declaring an annual export volume of 50 kg (≤1 ton, exempt from full formal registration) to obtain a REACH pre-registration number meeting minimum EU customs clearance compliance requirements.
· Factory GMP compliance certification: Coordinate partner manufacturers to conduct GMP compliance audits via the China Chamber of Commerce for Import and Export of Medicines and Health Products, issuing EMA-standard GMP certificates within 3 days to verify factory production environments and quality control workflows meet pharmaceutical-grade criteria.
· Compile DMF + full impurity traceability reports: Assist manufacturers in organizing production processes, quality standards, and impurity control protocols to compile dedicated BINAP DMF files for client filing. Generate full impurity traceability reports based on GC-MS and HPLC test data, clarifying sources and control measures for heavy metals (≤0.5 ppm), residual solvents, and chiral impurities in line with USP pharmaceutical-grade standards.
· Supplement batch traceability + third-party audit reports: Integrate batch production records, raw material procurement vouchers, equipment calibration records, and quality control records to form complete batch traceability files. Entrust SGS to conduct third-party factory audits and issue audit reports satisfying client internal quality review requirements.
· Process compliant Certificate of Origin (CO): Assist manufacturers in applying for a general Certificate of Origin (CO) from the China Council for the Promotion of International Trade, marking BINAP origin, manufacturer, and HS code (29319000) to certify Chinese origin and satisfy EU tariff and traceability requirements.
· Build full-process traceability archives: Integrate raw material procurement contracts, production process flowcharts, batch COA reports, SDS reports, export customs declarations, and CO certificates into electronic traceability archives. Clients may query full-process information via batch numbers, complying with EU pharmaceutical traceability supervision.
· Precise HS code classification: Confirm BINAP HS code 29319000 (organophosphorus compounds) to avoid customs clearance delays from misclassification, and supply classification explanations for client customs declaration use.
· Full customs clearance support: Deliver a complete customs clearance document checklist (SDS, SVHC reports, GMP certificates, COA, Certificate of Origin, customs declarations) and assist the client with EU customs filing, enabling smooth customs clearance within 2 days with zero detention fees.
· Establish long-term compliance mechanism: Sign a Long-Term Compliance Guarantee Agreement with the client with the following commitments:
o Annual updates of REACH compliance documents and SVHC test reports
o Quarterly reviews of factory GMP compliance status
o Real-time synchronization of EU regulatory updates with proactive compliance strategy adjustments
o 24-hour compliance consulting service for rapid response to compliance issues
The initial 20 kg BINAP shipment cleared customs smoothly without fines or delays. Full incoming testing by the client confirmed purity 99.85%, ee value 99.68%, heavy metals 0.4 ppm, and all impurities qualified. GMP documentation passed EMA audits 100%, and raw materials were successfully introduced to anti-tumor drug production lines with product quality matching Japanese imported equivalents.
The client’s Quality Director commented: "Compliance is the lifeline for high-end pharmaceutical enterprises. HiSiaddi fully resolved our three core compliance hurdles of REACH, GMP, and traceability, delivering a closed compliance loop within 7 days with documentation fully aligned with EU standards. The team prevented substantial economic losses and drug launch delays, demonstrating professionalism, efficiency, and reliability as a long-term trusted compliance partner."
The client awarded HiSiaddi the full annual 50 kg BINAP order and entrusted additional high-end customization demands including S-BINAP and sulfonated BINAP to HiSiaddi’s integrated solution covering procurement, quality control, traceability, and compliance services. A 3-year framework cooperation agreement was signed, stipulating all future Chinese raw material procurement shall undergo compliance review by HiSiaddi.
Core compliance pain point of mid-to-high-end clients: Missing REACH registration, incomplete GMP documentation, and broken supply chain traceability. Compliance directly determines market access to the EU and eligibility for pharmaceutical production lines, ranking above pricing as the primary factor in high-end client procurement decisions.
HiSiaddi core value: Beyond basic cargo transportation, HiSiaddi acts as a cross-border compliance expert with professional capabilities covering REACH regulations, GMP auditing, and supply chain traceability. We rapidly integrate resources to deliver one-stop compliance solutions and help clients mitigate compliance risks.
Core logic for compliance services: For EU pharmaceutical-grade clients, precise alignment with REACH, EMA, and GMP three-tier compliance systems is mandatory, supplemented by complete SDS, SVHC reports, GMP certificates, DMF, and traceability documentation. Establishing long-term compliance guarantee mechanisms fully addresses mid-to-high-end client demands and enables sustained long-term cooperation.
Contact HiSiaddi customer service for more inquiries on BINAP product compliance.